Our Management Team

	KEN PAIGE –CEO Ken brings diverse experience and talent to his role in providing the leadership to position CPL in the forefront of the industry. Ken’s career with CPL began in 2001 as a member of the Board of Directors and in-house executive focusing primarily in the areas of corporate development and strategic planning. Ken has been instrumental in the shaping of CPL, negotiating and executing the acquisitions of both the Innopharm and CPL Niagara operations and he played an instrumental role in the planning and implementation of Lean Manufacturing at CPL. Prior to his tenure at CPL, Ken held executive positions for over 20 years in finance, manufacturing operations, marketing and general management in both large private and public companies. Ken is a Chartered Accountant by profession having practiced public accounting with Price Waterhouse specializing in corporate taxation and he holds a Certified Director designation from the Institute of Corporate Directors.
	JOHN ROSS – Chief Operating Officer John’s responsibility includes operations of the Danbro and Buffalo facilities to ensure timely and efficient manufacturing of drug products in a cGMP compliant environment while meeting CPL’s growth objectives and strategic priorities. John joined CPL in April 2000. He most recently headed the CPL Niagara site as General Manager where he successfully led the transition to a fully integrated pharmaceutical provider. Prior to Niagara, John directed CPL Canada's sales, marketing, technology transfer, customer service, planning and materials management functions as the Vice President of Business Development and Customer Service. John holds a B.Sc. degree in mathematics and a Masters in Business Administration from the University of Western Ontario (London). Prior to CPL, John worked for PricewaterhouseCoopers in management consulting focused on supply chain optimization for consumer and industrial products companies. Additionally, John worked for Eli Lilly Inc in sales, finance and strategic planning.
	COLIN McCLINTOCK - Vice President, Quality In his role as Vice President of Quality, Colin is responsible for ensuring the continued cGMP compliance of the Danbro and Niagara operations as well as driving the strategic quality initiatives for these sites. Colin joined CPL in July of 2003. Prior to joining CPL Colin worked at W.K. Buckley Ltd. as the Director of Scientific Affairs for 5 years, and previous to this held positions of increasing responsibility in Quality management for Boehringer Ingelheim Canada Ltd. Colin holds a Bachelor of Science degree in Chemistry from the University of Toronto.
	JAN SAHAI – Vice President, Business Development In his role as Vice President, Business Development, Jan is responsible for developing new business opportunities for all the CPL sites, as well as participating in the formulation and implementation of strategic plans, coordinating CPL marketing activities and building strong business relationships with new and existing clients. Jan joined CPL in September 2005. Prior to joining CPL, Jan worked at GSK where he held progressively senior roles in sales (National Sales Manager, Specialty products), marketing (Marketing Director, CNS) and Corporate Communications. Additionally, Jan was an Assistant Professor of Medicine and Director of the Clinical Investigation Unit at the University of Ottawa School of Medicine from 1989 to 1996. Jan holds a Doctor of Pharmacy degree from the Philadelphia College of Pharmacy, a post-doctorate research fellowship from the Medical College of Virginia and a Masters of Business Administration degree from the University of Western Ontario.
	BRENT MATTHEWS – General Manager, Innopharm Brent’s functions as General Manager include responsibility for the day-to-day operations for CPL’s analytical testing division, Innopharm, as well as participating in the formation and implementation of strategic plans, developing and controlling the site budget, liaising with customers concerning operational matters and enhancing operational performance. Brent joined CPL in September 2004. Prior to joining CPL, Brent worked at Biovail Contract Research as the Director of their Bioanalytical Laboratory at their Scarborough, Ontario facility. Additionally, Brent worked for Novopharm Limited, where he held several positions including Senior Manager R&D Compliance and Laboratory Manager. Brent holds a B.Sc. degree in Chemistry from the University of Waterloo.